The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

ConditionsPSMA PET/CT Prostate Cancer MpMRI

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age40+

SponsorNanjing First Hospital, Nanjing Medical University

About this trial

The present study is designed to explore the value of targeted puncture guided by PSMA PET/CT or mpMRI in the diagnosis of patients with low PSA and initial negative prostate biopsy

Eligibility criteria

Qualifiers

Age ≥40 years, male;

Serum PSA level 4-20 ng/mL;

No contraindications to PSMA-PET/CT or MRI;

Disqualifiers

Serum PSA >20 ng/mL;

History of prostate surgery/radiotherapy;

Acute prostatitis;

Coagulation disorders or active infection;

Trial design

Treatments tested in this trial

Prostate biopsy guided by PSMA PET/CT
Prostate biopsy guided by mpMRI/US
Systematic prostate biopsy

Treatment groups

120 Participants

are divided into 4 treatment groups

Sponsors and collaborators

Nanjing First Hospital, Nanjing Medical University

Lead sponsor

Source ClinicalTrials.gov